Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata
This study has been completed.
Study NCT00063076   Information provided by M.D. Anderson Cancer Center
First Received: June 19, 2003   Last Updated: October 22, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alopecia Areata
Additional conditions recognized in this trial
Alopecia
More general conditions related to this trial
Hair Diseases
Hypotrichosis
Pathological Conditions, Anatomical
Skin Diseases
Interventions listed in this trial
Targretin Gel 1%
Additional drug interventions recognized in this trial
Bexarotene
More general drug interventions related to this trial
Anticarcinogenic Agents
Antineoplastic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
M.D. Anderson Cancer Center
Ligand Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services